Is Elevance Health Inc. (ELV) a Buy, Sell, or Hold?
NYSE : ELV
Elevance Health Inc. — Stock Grades
$377.68 USD
-$1.63 (-0.43%)
- Volume
- 734.83K
- Average Volume
- 1.74M
- Market Capitalization
- $81.91B
- P/E Ratio
- 16.79
- Dividend Yield
- 1.82%
- Price Target
- $452.50
- Year High
- $436.24
- Year Low
- $273.71
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.30
- Current Ratio
- $1.52
ELV Stock Grades
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2026-07-17 | Leerink Partners | Market Perform | Market Perform | Maintain |
| 2026-07-16 | Guggenheim | Buy | Buy | Maintain |
| 2026-07-16 | Barclays | Overweight | Overweight | Maintain |
| 2026-07-16 | Baird | Neutral | Neutral | Maintain |
| 2026-07-16 | RBC Capital | Sector Perform | Sector Perform | Maintain |
| 2026-07-16 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-07-14 | Truist Securities | Buy | Buy | Maintain |
| 2026-07-14 | TD Cowen | Buy | Buy | Maintain |
| 2026-07-13 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-07-09 | RBC Capital | Sector Perform | Sector Perform | Maintain |
| 2026-07-07 | Cantor Fitzgerald | Overweight | Overweight | Maintain |
| 2026-07-02 | Bernstein | Outperform | Outperform | Maintain |
| 2026-06-08 | Mizuho | Outperform | Outperform | Maintain |
| 2026-06-08 | JP Morgan | Overweight | Overweight | Maintain |
| 2026-06-04 | Morgan Stanley | Equal Weight | Equal Weight | Maintain |
| 2026-06-04 | B of A Securities | Buy | Buy | Maintain |
| 2026-06-01 | Truist Securities | Buy | Buy | Maintain |
| 2026-05-26 | Barclays | Overweight | Overweight | Maintain |
| 2026-05-22 | UBS | Buy | Buy | Maintain |
| 2026-05-20 | Mizuho | Outperform | Outperform | Maintain |
| 2026-05-20 | Deutsche Bank | Hold | Buy | Upgrade |
| 2026-04-29 | B of A Securities | Neutral | Buy | Upgrade |
| 2026-04-28 | JP Morgan | Overweight | Overweight | Maintain |
| 2026-04-24 | Barclays | Overweight | Overweight | Maintain |
| 2026-04-24 | Bernstein | Outperform | Outperform | Maintain |
| 2026-04-24 | Guggenheim | Buy | Buy | Maintain |
| 2026-04-23 | Baird | Neutral | Neutral | Maintain |
| 2026-04-23 | Evercore ISI Group | In Line | In Line | Maintain |
| 2026-04-20 | Jefferies | Buy | Buy | Maintain |
| 2026-04-13 | Truist Securities | Buy | Buy | Maintain |
| 2026-03-11 | Mizuho | Outperform | Outperform | Maintain |
| 2026-02-02 | Truist Securities | Buy | Buy | Maintain |
| 2026-02-02 | Bernstein | Outperform | Outperform | Maintain |
| 2026-02-02 | JP Morgan | Overweight | Overweight | Maintain |
| 2026-01-30 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-01-30 | Barclays | Overweight | Overweight | Maintain |
| 2026-01-29 | Guggenheim | Buy | Buy | Maintain |
| 2026-01-22 | Guggenheim | Buy | Buy | Maintain |
| 2026-01-08 | Wolfe Research | Peer Perform | Outperform | Upgrade |
| 2026-01-07 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-01-05 | Barclays | Overweight | Overweight | Maintain |